Skip to content

Comparison of Osteoporosis Disease Management Strategies (0000-039)

Evaluation of Strategies for Increasing Osteoporosis Screening and Treatment in a Managed Care Organization

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00145080
Enrollment
4685
Registered
2005-09-05
Start date
2004-07-31
Completion date
2006-01-31
Last updated
2015-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Brief summary

The purpose of this study is to assess the impact of disease management interventions on bone mineral density screening rates and osteoporosis treatment rates in women age 50-64 years at high risk for osteoporosis.

Interventions

Sponsors

Merck Sharp & Dohme LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Members of the Harvard Pilgrim Health Plan

Exclusion criteria

* Individuals who are not members of the Harvard Pilgrim Health Plan

Design outcomes

Primary

MeasureTime frame
Bone mineral density screening rates

Secondary

MeasureTime frame
Medications adoptions; Medications adherence

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026